Michael Kneissl

Title: Michael Kneissl: Innovator in UV Antisepsis Technology

Introduction

Michael Kneissl is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of antisepsis through his innovative device and method for UV antisepsis. His work focuses on addressing the challenges posed by multiresistant pathogens, which are a growing concern in medical settings.

Latest Patents

Kneissl holds a patent for a device and method for UV antisepsis. This invention is particularly aimed at intracorporeal in vivo UV antisepsis on the human and animal body in cases of colonization with multiresistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus epidermidis (MRSE). The device features a light-emitting diode (LED) chip that emits radiation in the UVC spectral range. It includes a spectral filter element that limits the emitted radiation to wavelengths below 235 nm, along with an optical element for directional emission of the radiation.

Career Highlights

Throughout his career, Michael Kneissl has worked with prominent institutions such as Universitätsmedizin Greifswald and Charité-Universitätsmedizin Berlin. His experience in these esteemed organizations has allowed him to develop and refine his innovative technologies in the medical field.

Collaborations

Kneissl has collaborated with notable colleagues, including Martina Meinke and Jürgen Lademann. These partnerships have contributed to the advancement of his research and the successful development of his patented technology.

Conclusion

Michael Kneissl's work in UV antisepsis represents a significant advancement in the fight against multiresistant pathogens. His innovative device and method have the potential to improve medical outcomes and enhance patient safety.